Postoperative Renal Dysfunction Independently Predicts Late Mortality in Patients Undergoing Aortic Reconstruction  by Patel, Virendra I. et al.





















CAS 0.0% 0.0% 4.7% 7.9% 0.0% 0.0% 6.3% 7.9%
CEA 0.6% 1.3% 1.0% 1.9% 1.4% 2.6% 1.8% 2.9%
JOURNAL OF VASCULAR SURGERY
852 Abstracts September 2013Postoperative Renal Dysfunction Independently Predicts Late
Mortality in Patients Undergoing Aortic Reconstruction
Virendra I. Patel,1 Robert T. Lancaster,1 Emel Ergul,1 Mark F. Conrad,1
Daniel Bertges,2 Marc Schermerhorn,3 Phillip Goodney,4 Richard P.
Cambria1. 1Massachusetts General Hospital, Boston, Mass; 2Flether Allan
Medical Center, Burlington, Vt; 3Beth Israel Deaconess Medical Center,
Boston, Mass; 4Dartmouth-Hitchcock Medical Center, Lebanon, NH
Objectives: Preoperative chronic kidney disease (CKD) has been
shown to predict postoperative renal complications and late survival
following aortic surgery, whereas the impact of postoperative renal compli-
cations less severe than permanent dialysis are unknown. We evaluated the
effect of increasingly severe postoperative renal dysfunction on survival using
a regional quality improvement registry.
Methods: Patients undergoing intact open aortic reconstruction in
the Vascular Study Group of New England registry (2003-2012) were strat-
iﬁed by severity of postoperative renal complications; none, creatinine
increase >0.5 mg/dL (IncCr), or any dialysis (HD). Predictors of renal
dysfunction and impact of renal complications on survival were analyzed
using multivariable methods.
Results: A total of 2095 patients were included, of which 72% had
open abdominal aortic aneurysm repair, and 28% open aortoiliac reconstruc-
tion. Of these, 15% of patients had moderate CKD, and 1.2% had severe
CKD at baseline. Postoperatuve renal complications were none in 90%,
IncCr in 8.6%, and HD in 1.6%. Multivariable cumlogit regression identiﬁed
moderate CKD (odds ratio [OR], 2.7; 95% conﬁdence interval [CI], 1.8-3.9;
P< .01), severe CKD (OR, 17; 95% CI, 7-41; P< .01), operating room time
(OR, 1.004 minutes; 95% CI, 1.003-1.006; P < .01), and supra-renal clamp
use (OR, 2.1; 95% CI, 1.4-2.9; P < .01) as independent predictors of wors-
ening strata of postoperative renal dysfunction. Risk-adjusted multivariable
Cox regression showed that IncCr (hazard ratio, 1.6; 95% CI, 1.1-2.3;
P ¼ .01) and HD (hazard ratio, 3.2; 95% CI, 1.8-5.7; P < .01) increased
risk of late death independent of age, gender, baseline moderate or severe
CKD, congestive heart failure, chronic obstructive pulmonary disease, and
postoperative myocardial infarction or death. Five-year survival was lower
(log rank P < .01) in patients with IncCr (71% 6 4%), and HD (29% 6
10%) compared with those with none (79% 6 1%; Fig).
Conclusions: Increasing severity of postoperative renal dysfunction
independently predicts increased risk of late mortality after open aortic
surgery. Perioperative measures to reduce renal complications may poten-
tially prolong the survival of patients following open aortic surgery.P value .36 .33 <.01 <.01 .15 .17 <.01 .02
CAS, Carotid artery stenting; CEA, carotid endarterectomy.
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Objectives: In medically high-risk patients, the choice between
carotid artery stenting (CAS) and carotid endarterectomy (CEA) can be
difﬁcult. The purpose of this study was to compare risk-stratiﬁed outcomes
of CAS and CEA.Methods: Patients undergoing primary CEA (n ¼ 10,541) or primary
CAS (n ¼ 424) at 26 centers in the Vascular Study Group of New England
were analyzed (2003-2012); patients with prior ipsilateral CEA or CAS
were excluded. A medical risk score based on the risk of death within 5 years
was developed for each patient using a Cox proportional hazards model.
Patients in the highest risk quartile were termed high-risk (vs normal risk
for the other three quartiles). Risk-stratiﬁed outcomes were compared
between neurologically symptomatic and asymptomatic patients.
Results: Patients undergoing CAS had a higher prevalence of coro-
nary artery disease, congestive heart failure, diabetes, chronic obstructive
pulmonary disease, and contralateral internal carotid artery occlusion.
Neurologic symptom status was not different (CAS, 43% vs CEA, 40%
symptomatic). Overall 5-year survival was 80%. Medically high-risk patients
had a 5-year survival of 60% and comprised 25% of CEA and 35% of CAS.
Among asymptomatic patients rates of in-hospital stroke/death, and
stroke/death/myocardial infarction were not different between CAS and
CEA in both normal- and high-risk cohorts. Among symptomatic patients,
CAS had signiﬁcantly higher event rates for both normal- and high-risk
cohorts (Table). CAS outcomes did not correlate with operator annual-
ized stent volume.
Conclusions: In the Vascular Study Group of New England, asymp-
tomatic normal- and high-risk patients do equally well after CEA or CAS.
However, both normal- and high-risk symptomatic patients have substan-
tially worse outcomes with CAS as compared with CEA. Symptom status
is more important than medical risk when recommending CAS.Racial Disparity in Hemodialysis Access Types in Patients with End-
Stage Renal Disease: An Analysis of the United States Renal Database
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Objectives: To examine racial and ethnic inﬂuences on hemodialysis
initiation modes with arteriovenous ﬁstula (AVF), arteriovenous graft
(AVG), and intravenous hemodialysis (HD) catheter (IHC) in patients
with end-stage renal disease (ESRD).
Methods: A retrospective analysis of a prospectively collected data-
base comprising all ESRD patients receiving renal replacement therapy
maintained by the United States Renal Database System between 2006
and 2010 was performed with institutional review board approval. c2 tests
and analysis of variance provided descriptive statistics.
Results: Examined were 2,377,166 ESRD patients. We excluded all
patients with IHC, AVF, or AVG prior to 2006, those not classiﬁed as white,
black, orHispanic, and patients with prior kidney transplants. Patients totaling
482,988 were included, of whom 82.7% initiated HD via IHC versus 13.9%
via AVF and 3.4% via AVG.White patients were older (65.9 years) at initiation
than black (58.4 years) and Hispanic (58.0 years) patients (P < .001). Black
patients were more likely to be female (48.1%) than white (41.2%) and
Hispanic (42.9%) patients (P < .001). HD initiation with AVF was more
common among white patients (15.2%) than black (12.5%) or Hispanic
(11.8%) patients, whereas AVG was more common among black patients
(4.9%) than white (2.9%) or Hispanic (2.6%) patients (P < .001; Table).
Conclusions: White ESRD patients initiate HD with AVF more
frequently than black or Hispanic patients. This disparity between white
and black patients derives not from procedure rate, but rather from conduit
selection. Black patients receive AVG two-thirds more frequently, while
undergoing surgery at clinically similar rates. Hispanic patients receive fewer
ﬁstulas and grafts, as well as more catheters, in comparison to the other
